• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肝细胞癌患者局部区域治疗后的影像检查：基于文献的综述

Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review.

作者信息

Young Shamar, Taylor Andrew J, Sanghvi Tina

机构信息

Department of Radiology, University of Minnesota, Minneapolis, MN, USA.

出版信息

J Clin Transl Hepatol. 2018 Jun 28;6(2):189-197. doi: 10.14218/JCTH.2017.00059. Epub 2018 Feb 14.

DOI:10.14218/JCTH.2017.00059
PMID:29951364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6018307/
Abstract

Imaging plays a crucial role in the diagnosis of hepatocellular carcinoma (HCC) as well as in determining treatment efficacy, or complications, following therapy. Unlike other cancers, HCC is most commonly treated by locoregional therapies (LRTs) such as thermal ablation, transarterial chemoembolization, and transarterial radioembolization. These treatments can lead to changes on imaging that make determination of residual/recurrent disease difficult. This literature-based review discusses the expected postimaging findings following LRT.

摘要

成像在肝细胞癌（HCC）的诊断以及确定治疗效果或治疗后并发症方面起着至关重要的作用。与其他癌症不同，HCC最常通过局部区域治疗（LRTs）进行治疗，如热消融、经动脉化疗栓塞和经动脉放射性栓塞。这些治疗可导致成像上的变化，使得确定残留/复发性疾病变得困难。这篇基于文献的综述讨论了LRT后预期的成像结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/9f4ebe6ef816/JCTH-6-189-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/4cf0bd54b24f/JCTH-6-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/9a768656696c/JCTH-6-189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/959a3da94b13/JCTH-6-189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/3f6d2facac41/JCTH-6-189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/0e93d1d77e9a/JCTH-6-189-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/2c6f8eb51ed1/JCTH-6-189-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/9f4ebe6ef816/JCTH-6-189-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/4cf0bd54b24f/JCTH-6-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/9a768656696c/JCTH-6-189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/959a3da94b13/JCTH-6-189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/3f6d2facac41/JCTH-6-189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/0e93d1d77e9a/JCTH-6-189-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/2c6f8eb51ed1/JCTH-6-189-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e274/6018307/9f4ebe6ef816/JCTH-6-189-g007.jpg

相似文献

1
Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review.肝细胞癌患者局部区域治疗后的影像检查：基于文献的综述
J Clin Transl Hepatol. 2018 Jun 28;6(2):189-197. doi: 10.14218/JCTH.2017.00059. Epub 2018 Feb 14.
2
Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.经动脉放射性栓塞联合化疗栓塞治疗双叶肝细胞癌的安全性和有效性：一项单中心回顾性研究
Cardiovasc Intervent Radiol. 2018 Mar;41(3):459-465. doi: 10.1007/s00270-017-1826-7. Epub 2017 Oct 24.
3
Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.肝细胞癌经动脉化疗栓塞与经动脉放射性栓塞治疗：治疗方式选择的优化
Hepatol Int. 2016 Nov;10(6):883-892. doi: 10.1007/s12072-016-9722-9. Epub 2016 Apr 28.
4
Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma.比较不可切除肝细胞癌患者经动脉化疗栓塞术和经动脉放射栓塞术治疗后的健康相关生活质量。
Abdom Radiol (NY). 2019 Apr;44(4):1554-1561. doi: 10.1007/s00261-018-1802-y.
5
Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.3-5cm 肝细胞癌的局部区域治疗：文献综述的批判性评价。
AJR Am J Roentgenol. 2020 Jul;215(1):223-234. doi: 10.2214/AJR.19.22098. Epub 2020 Apr 7.
6
In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?中晚期肝细胞癌：钇 90 放射性栓塞治疗还是化疗栓塞治疗？
Liver Int. 2015 Feb;35(2):627-35. doi: 10.1111/liv.12637. Epub 2014 Aug 2.
7
Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.经动脉化疗栓塞术和（90）钇放射性栓塞术治疗肝细胞癌：超越中期疾病的当前应用综述。
AJR Am J Roentgenol. 2015 Oct;205(4):742-52. doi: 10.2214/AJR.15.14802.
8
Successful Transcatheter Arterial Radioembolization of Hepatocellular Carcinoma Via Left Internal Mammary Artery: A Case Report.经左乳内动脉成功进行肝细胞癌的经导管动脉放射性栓塞术：一例报告
Cureus. 2022 Mar 8;14(3):e22954. doi: 10.7759/cureus.22954. eCollection 2022 Mar.
9
Locoregional Therapies of Cholangiocarcinoma.胆管癌的局部区域治疗
Visc Med. 2016 Dec;32(6):414-420. doi: 10.1159/000453010. Epub 2016 Dec 5.
10
Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma.探讨局部区域联合治疗与免疫治疗在肝细胞癌治疗中的疗效与安全性。
Biomedicines. 2024 Jun 27;12(7):1432. doi: 10.3390/biomedicines12071432.

引用本文的文献

1
Thermal and Magnetic Dual-Responsive Catheter-Assisted Shape Memory Microrobots for Multistage Vascular Embolization.用于多阶段血管栓塞的热磁双响应导管辅助形状记忆微型机器人
Research (Wash D C). 2024 Mar 26;7:0339. doi: 10.34133/research.0339. eCollection 2024.
2
Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.对比增强超声在评估肝癌经栓塞化疗后疗效的前瞻性多中心研究。
Radiology. 2023 Oct;309(1):e230727. doi: 10.1148/radiol.230727.
3
A real-world analysis of survival and cost-effectiveness of sintilimab plus bevacizumab biosimilar regimen in patients with advanced hepatocellular carcinoma.

本文引用的文献

1
Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis.射频消融与其他消融技术对肝细胞癌的影响：一项系统评价和荟萃分析
World J Surg Oncol. 2017 Jul 10;15(1):126. doi: 10.1186/s12957-017-1196-2.
2
Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.不可热消融技术治疗的肝细胞癌患者行不可逆电穿孔治疗的安全性和疗效：一项回顾性单中心病例系列研究。
Radiology. 2017 Sep;284(3):877-886. doi: 10.1148/radiol.2017161413. Epub 2017 Apr 28.
3
真实世界研究分析信迪利单抗联合贝伐珠单抗生物类似药方案治疗晚期肝细胞癌患者的生存获益和成本效益。
J Cancer Res Clin Oncol. 2023 Sep;149(11):9213-9219. doi: 10.1007/s00432-023-04775-2. Epub 2023 May 16.
4
Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization.药物洗脱微球经导管动脉化疗栓塞术后肝细胞癌瘤周边缘强化的磁共振图像与预后的相关性
Front Oncol. 2023 Apr 4;13:957710. doi: 10.3389/fonc.2023.957710. eCollection 2023.
5
Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment.钆塞酸增强肝脏磁共振成像在局部治疗后肝细胞癌评估中的作用。
World J Gastroenterol. 2022 Jul 14;28(26):3116-3131. doi: 10.3748/wjg.v28.i26.3116.
6
Current Imaging Diagnosis of Hepatocellular Carcinoma.肝细胞癌的当前影像诊断
Cancers (Basel). 2022 Aug 18;14(16):3997. doi: 10.3390/cancers14163997.
7
MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review.局部区域治疗后经治疗的肝细胞癌的MRI特征：图谱综述
Abdom Radiol (NY). 2022 Jul;47(7):2299-2313. doi: 10.1007/s00261-022-03526-0. Epub 2022 May 7.
8
MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review.MRI 评估局部区域治疗后肝细胞癌：全面综述。
Radiol Imaging Cancer. 2020 Jan 31;2(1):e190024. doi: 10.1148/rycan.2020190024. eCollection 2020 Jan.
9
Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer.应用碘油作为影像生物标志物的自动特征量化来预测肝癌常规经动脉化疗栓塞的治疗效果。
Sci Rep. 2020 Oct 22;10(1):18026. doi: 10.1038/s41598-020-75120-7.
10
Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization.230 例不可切除肝细胞癌患者行单纯性经肝动脉化疗栓塞治疗的生存分析。
PLoS One. 2020 Jan 14;15(1):e0227711. doi: 10.1371/journal.pone.0227711. eCollection 2020.
New concepts in embolotherapy of HCC.
肝癌栓塞治疗的新概念。
Med Oncol. 2017 Apr;34(4):58. doi: 10.1007/s12032-017-0917-2. Epub 2017 Mar 16.
4
AASLD guidelines for the treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌治疗指南。
Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086.
5
Intra-arterial therapies for liver cancer: assessing tumor response.肝癌的动脉内治疗：评估肿瘤反应。
Expert Rev Anticancer Ther. 2017 Feb;17(2):119-127. doi: 10.1080/14737140.2017.1273775. Epub 2016 Dec 27.
6
Current Guidelines for the Diagnosis and Management of Hepatocellular Carcinoma: A Comparative Review.当前肝细胞癌诊断和管理指南：比较综述。
AJR Am J Roentgenol. 2016 Nov;207(5):W88-W98. doi: 10.2214/AJR.15.15490. Epub 2016 Aug 4.
7
Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.肝细胞癌治疗的手术及非手术方法进展
Hepatobiliary Pancreat Dis Int. 2016 Jun;15(3):234-56. doi: 10.1016/s1499-3872(16)60097-8.
8
Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.扩散加权磁共振成像可预测以肝脏为主的转移性结直肠癌患者在选择性内放射治疗后不久的生存率。
Eur Radiol. 2017 Mar;27(3):966-975. doi: 10.1007/s00330-016-4430-3. Epub 2016 Jun 7.
9
Liver transplantation: Current status and challenges.肝移植：现状与挑战
World J Gastroenterol. 2016 May 14;22(18):4438-45. doi: 10.3748/wjg.v22.i18.4438.
10
Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery.接受局部放化疗和手术的肝细胞癌的放射病理学相关性研究
J Gastroenterol Hepatol. 2016 Sep;31(9):1619-27. doi: 10.1111/jgh.13334.